AU2005267396B2 - Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same - Google Patents

Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same Download PDF

Info

Publication number
AU2005267396B2
AU2005267396B2 AU2005267396A AU2005267396A AU2005267396B2 AU 2005267396 B2 AU2005267396 B2 AU 2005267396B2 AU 2005267396 A AU2005267396 A AU 2005267396A AU 2005267396 A AU2005267396 A AU 2005267396A AU 2005267396 B2 AU2005267396 B2 AU 2005267396B2
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
pharmaceutically acceptable
another embodiment
poly
active agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2005267396A
Other languages
English (en)
Other versions
AU2005267396A1 (en
Inventor
Yerramilli V. S. N. Murthy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idexx Laboratories Inc
Original Assignee
Idexx Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/874,552 external-priority patent/US7618651B2/en
Application filed by Idexx Laboratories Inc filed Critical Idexx Laboratories Inc
Publication of AU2005267396A1 publication Critical patent/AU2005267396A1/en
Application granted granted Critical
Publication of AU2005267396B2 publication Critical patent/AU2005267396B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2005267396A 2004-06-24 2005-06-23 Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same Expired AU2005267396B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/874,552 2004-06-24
US10/874,552 US7618651B2 (en) 2004-06-24 2004-06-24 Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
US11/019,243 2004-12-23
US11/019,243 US7622138B2 (en) 2004-06-24 2004-12-23 Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
PCT/US2005/022073 WO2006012146A2 (en) 2004-06-24 2005-06-23 Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same

Publications (2)

Publication Number Publication Date
AU2005267396A1 AU2005267396A1 (en) 2006-02-02
AU2005267396B2 true AU2005267396B2 (en) 2009-09-17

Family

ID=35786640

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005267396A Expired AU2005267396B2 (en) 2004-06-24 2005-06-23 Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same

Country Status (5)

Country Link
EP (1) EP1765293B1 (enExample)
JP (1) JP5324091B2 (enExample)
AU (1) AU2005267396B2 (enExample)
CA (1) CA2570599C (enExample)
WO (1) WO2006012146A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006103638A2 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Topical pharmaceutical compositions of terbinafine and processes for their preparation
HUP0700828A2 (en) * 2007-12-20 2010-01-28 Richter Gedeon Nyrt Transdermal pharmaceutical compositions containing tolperisone alone and in combination
EP2143421A1 (en) * 2008-07-07 2010-01-13 Almirall Hermal GmbH Topical composition for the treatment of actinic keratosis
SE536091C2 (sv) * 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6087215A (ja) * 1983-10-19 1985-05-16 Mitsui Toatsu Chem Inc 外用薬用基材
US6669958B1 (en) * 1997-02-20 2003-12-30 Biomedicines, Inc. Gel delivery vehicles for anticellular proliferative agents

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678516A (en) * 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
US4843096A (en) * 1985-06-26 1989-06-27 Stiefel Laboratories, Inc. Treatment of acne
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
EP0865292A4 (en) * 1995-11-22 2002-01-02 Intrabiotics Pharmaceuticals COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF INFLAMMATION OF THE ORAL MUCOSA
GB9718791D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Medicaments
US6238683B1 (en) * 1998-12-04 2001-05-29 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
IT1308187B1 (it) * 1999-02-16 2001-12-07 Formenti Farmaceutici Spa Composizioni farmaceutiche topiche a base di antiinfiammatori nonsteroidei.
JP4195178B2 (ja) * 1999-11-10 2008-12-10 東興薬品工業株式会社 消炎鎮痛外用剤
FR2802810A1 (fr) * 1999-12-23 2001-06-29 Grinda Jean Robert Nouveaux produits cosmetiques et therapeutiques a base de composes lipidiques et leur procede de preparation
JP2001245913A (ja) * 1999-12-28 2001-09-11 Lion Corp 非水系温熱ゲル組成物
TWI232758B (en) * 2000-03-21 2005-05-21 Jiun-Ren Chen High concentration vitamin C composition and method for preparing the same
WO2003094917A1 (en) * 2002-05-13 2003-11-20 Takata Seiyaku Co., Ltd. Vintoperol-containing medicinal composition for transdermal administration

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6087215A (ja) * 1983-10-19 1985-05-16 Mitsui Toatsu Chem Inc 外用薬用基材
US6669958B1 (en) * 1997-02-20 2003-12-30 Biomedicines, Inc. Gel delivery vehicles for anticellular proliferative agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Handbook of Pharmaceutical Controlled Release Technology (ed Wise) 2000 *

Also Published As

Publication number Publication date
AU2005267396A1 (en) 2006-02-02
CA2570599A1 (en) 2006-02-02
WO2006012146A2 (en) 2006-02-02
JP5324091B2 (ja) 2013-10-23
EP1765293A2 (en) 2007-03-28
CA2570599C (en) 2012-03-27
WO2006012146A3 (en) 2007-02-01
EP1765293B1 (en) 2014-10-01
JP2008504272A (ja) 2008-02-14
EP1765293A4 (en) 2012-05-30

Similar Documents

Publication Publication Date Title
US7622138B2 (en) Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
US8361496B2 (en) Phospholipid gel compositions for drug delivery and methods of treating conditions using same
ES2396598T3 (es) Preparaciones en forma de suspensiones acuosas
US7854943B2 (en) Phospholipid gel compositions for drug delivery and methods of treating conditions using same
JP2002504523A (ja) 肛門部の痛みのある状態を治療するための方法及びそのための組成物
US10039709B2 (en) Bioadhesive compositions for epithelial drug delivery
EP2074990B1 (en) Controlled release flurbiprofen and muscle relaxant combinations
AU2005267396B2 (en) Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
AU2024276277A1 (en) Pharmaceutical composition
US8236814B2 (en) Composition and method for treatment of warts
JP3187806B2 (ja) ニトロイミダゾール系化合物を含むアトピー性皮膚炎治療用の外用剤
JP2001163783A (ja) 皮膚疾患治療用外用剤
JP3538367B2 (ja) 皮膚組織障害治療・予防・改善用外用剤
JP3568881B2 (ja) 皮膚疾患治療用外用剤
US20060222712A1 (en) Acne gel

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired